stoxline Quote Chart Rank Option Currency Glossary
  
Creative Medical Technology Holdings, Inc. (CELZ)
2.14  0.05 (2.39%)    05-09 16:00
Open: 2.12
High: 2.19
Volume: 35,029
  
Pre. Close: 2.09
Low: 1.9602
Market Cap: 6(M)
Technical analysis
2025-05-10 10:00:36 AM
Short term     
Mid term     
Targets 6-month :  2.83 1-year :  3.31
Resists First :  2.43 Second :  2.83
Pivot price 2
Supports First :  1.97 Second :  1.69
MAs MA(5) :  2.03 MA(20) :  2.01
MA(100) :  2.94 MA(250) :  3.27
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  67.9 D(3) :  53.4
RSI RSI(14): 48.3
52-week High :  6.9 Low :  1.69
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CELZ ] has closed It is unclear right now based on current values. 84.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.19 - 2.2 2.2 - 2.21
Low: 1.94 - 1.95 1.95 - 1.96
Close: 2.12 - 2.14 2.14 - 2.15
Company Description

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Headline News

Fri, 09 May 2025
Creative Medical Technology Holdings Inc expected to post a loss of 40 cents a share - Earnings Preview - TradingView

Fri, 09 May 2025
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Tue, 06 May 2025
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain - Barchart.com

Sun, 27 Apr 2025
Companies Like Creative Medical Technology Holdings (NASDAQ:CELZ) Are In A Position To Invest In Growth - Yahoo Finance

Tue, 25 Mar 2025
Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - Nasdaq

Sun, 16 Mar 2025
Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 3 (M)
Held by Insiders 1.75e+006 (%)
Held by Institutions 1.4 (%)
Shares Short 65 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -5.63e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -62 %
Return on Assets (ttm) 857.7 %
Return on Equity (ttm) -41.3 %
Qtrly Rev. Growth 11000 %
Gross Profit (p.s.) 0
Sales Per Share -13.58
EBITDA (p.s.) 1360.82
Qtrly Earnings Growth -3.8 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.16
Price to Cash Flow 2.85
Stock Dividends
Dividend 0
Forward Dividend 44990
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android